This is also when youll probably be adjusting your dose
Semaglutide, a mimic of glucagon-like peptide-1 (GLP-1), has garnered approval for managing type 2 diabetes (both orally and via subcutaneous injection) and for mitigating cardiovascular risks in those with type 2 diabetes and cardiovascular ailments (specifically through subcutaneous injection)
Many patients choose private prescriptions through services like UK Meds to bypass long waiting lists or because they do not meet the strict NHS "Phase 1" or "Phase 2" rollout criteria
Make sure to mention any previous blood clots, clotting disorders, chronic illnesses, and lifestyle factors like smoking or prolonged immobility
They only partner with FDA pharmacies, the provider told me, and she gave me the name of the pharmacy that would be compounding my peptides
Whether someone is switching treatments or completely new to GLP-1s, confidence comes from education